NovAccess Global Inc. (OTCMKTS:XSNX – Get Rating) saw a significant decline in short interest in January. As of January 31st, there was short interest totalling 3,900 shares, a decline of 25.0% from the January 15th total of 5,200 shares. Based on an average trading volume of 8,000 shares, the short-interest ratio is presently 0.5 days.
NovAccess Global Price Performance
XSNX stock opened at $0.21 on Tuesday. NovAccess Global has a 12 month low of $0.10 and a 12 month high of $0.60. The firm has a 50 day moving average of $0.21 and a two-hundred day moving average of $0.20.
Get NovAccess Global alerts:NovAccess Global Company Profile
(Get Rating)
NovAccess Global, Inc is a biopharmaceutical company, which engages in the provision of diagnostics, therapeutics in cancer, and neurological diseases and the development of immunotherapies to treat brain tumor patients. The company was founded on February 25, 1997 and is headquartered in Cuyahoga County, OH.Further Reading
- Get a free copy of the StockNews.com research report on NovAccess Global (XSNX)
- Should Medtronic's Recent Colibri Patent Controversy Concern You?
- Checkpoint Software Helps Cyber Security Stocks Bottom
- Under Armour Stock, Gap and Crap, Here's Why
- Is Chevron Positioned To Take Energy Sector Leadership?
- What Does the Consumer Price Index Measure?
Receive News & Ratings for NovAccess Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovAccess Global and related companies with MarketBeat.com's FREE daily email newsletter.